{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T21:25:34Z","timestamp":1780089934536,"version":"3.54.0"},"reference-count":7,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,11,11]],"date-time":"2022-11-11T00:00:00Z","timestamp":1668124800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["jidinnovations.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JID Innovations"],"published-print":{"date-parts":[[2023,3]]},"DOI":"10.1016\/j.xjidi.2022.100170","type":"journal-article","created":{"date-parts":[[2022,11,17]],"date-time":"2022-11-17T03:57:54Z","timestamp":1668657474000},"page":"100170","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Contact Sensitization and Phototoxic and Photoallergic Potential of Tirbanibulin 1% Ointment in Healthy Volunteers"],"prefix":"10.1016","volume":"3","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5952-3864","authenticated-orcid":false,"given":"Jonathan","family":"Dosik","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8164-1082","authenticated-orcid":false,"given":"David L.","family":"Cutler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0554-8836","authenticated-orcid":false,"given":"Jane","family":"Fang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2581-0707","authenticated-orcid":false,"given":"Laura","family":"Padull\u00e9s","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.xjidi.2022.100170_bib1","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1056\/NEJMoa2024040","article-title":"Phase 3 trials of tirbanibulin ointment for actinic keratosis","volume":"384","author":"Blauvelt","year":"2021","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.xjidi.2022.100170_bib2","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1111\/bjd.14680","article-title":"Patient-reported adherence and persistence to topical treatments for actinic keratosis: a longitudinal diary study","volume":"175","author":"Erntoft","year":"2016","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.xjidi.2022.100170_bib3","first-page":"1093","article-title":"Tirbanibulin ointment 1% as a novel treatment for actinic keratosis: phase 1 and 2 results","volume":"19","author":"Kempers","year":"2020","journal-title":"J\u00a0Drugs Dermatol"},{"key":"10.1016\/j.xjidi.2022.100170_bib7","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1111\/jdv.15142","volume":"33","author":"Neri","year":"2019","journal-title":"J\u00a0Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.xjidi.2022.100170_bib8","first-page":"35","article-title":"Non-adherence to topical treatments for actinic keratosis","volume":"8","author":"Shergill","year":"2013","journal-title":"Patient Prefer Adherence"},{"key":"10.1016\/j.xjidi.2022.100170_bib9","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1111\/ijd.12840","article-title":"A\u00a0consensus approach to improving patient adherence and persistence with topical treatment for actinic keratosis","volume":"54","author":"Stockfleth","year":"2015","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.xjidi.2022.100170_bib10","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1002\/cpdd.1041","article-title":"Phase I maximal use pharmacokinetic study of tirbanibulin ointment 1% in subjects with actinic keratosis","volume":"11","author":"Yavel","year":"2022","journal-title":"Clin Pharmacol Drug Dev"}],"container-title":["JID Innovations"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2667026722000789?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2667026722000789?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,13]],"date-time":"2025-11-13T08:04:02Z","timestamp":1763021042000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2667026722000789"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3]]},"references-count":7,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2023,3]]}},"alternative-id":["S2667026722000789"],"URL":"https:\/\/doi.org\/10.1016\/j.xjidi.2022.100170","relation":{},"ISSN":["2667-0267"],"issn-type":[{"value":"2667-0267","type":"print"}],"subject":[],"published":{"date-parts":[[2023,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Contact Sensitization and Phototoxic and Photoallergic Potential of Tirbanibulin 1% Ointment in Healthy Volunteers","name":"articletitle","label":"Article Title"},{"value":"JID Innovations","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.xjidi.2022.100170","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Authors. Published by Elsevier, Inc. on behalf of the Society for Investigative Dermatology.","name":"copyright","label":"Copyright"}],"article-number":"100170"}}